| Primary |
| Hypertension |
33.3% |
| Type 2 Diabetes Mellitus |
22.2% |
| Hyperlipidaemia |
11.1% |
| Ischaemic Heart Disease Prophylaxis |
11.1% |
| Prophylaxis Against Gastrointestinal Ulcer |
11.1% |
| Renal Impairment |
11.1% |
|
| Renal Failure Acute |
100.0% |
|
| Secondary |
| Hypertension |
40.7% |
| Coronary Artery Disease |
8.5% |
| Pain |
8.1% |
| Type 2 Diabetes Mellitus |
6.6% |
| Cardiac Failure |
5.6% |
| Atrial Fibrillation |
5.2% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.8% |
| Rheumatoid Arthritis |
2.8% |
| Hyperuricaemia |
2.7% |
| Prophylaxis |
2.7% |
| Renal Impairment |
2.5% |
| Product Used For Unknown Indication |
1.7% |
| Chronic Obstructive Pulmonary Disease |
1.5% |
| Hyperlipidaemia |
1.4% |
| Renal Failure |
1.4% |
| Dementia |
1.2% |
| Diabetes Mellitus |
1.2% |
| Gastrointestinal Motility Disorder |
1.2% |
| Hyperparathyroidism |
1.2% |
| Oedema |
1.2% |
|
| Renal Failure Acute |
29.8% |
| Vomiting |
12.4% |
| Syncope |
7.4% |
| Hyperglycaemia |
6.6% |
| Tachycardia |
5.8% |
| Drug Interaction |
5.0% |
| Fallot's Tetralogy |
4.1% |
| Renal Failure |
3.3% |
| Urinary Tract Infection |
3.3% |
| Blood Urea Increased |
2.5% |
| Prothrombin Time Abnormal |
2.5% |
| Prothrombin Time Prolonged |
2.5% |
| Rhabdomyolysis |
2.5% |
| Toxic Epidermal Necrolysis |
2.5% |
| Dehydration |
1.7% |
| General Physical Health Deterioration |
1.7% |
| Hypotension |
1.7% |
| Metabolic Alkalosis |
1.7% |
| Pre-eclampsia |
1.7% |
| Renal Impairment |
1.7% |
|
| Concomitant |
| Hypertension |
28.5% |
| Product Used For Unknown Indication |
12.2% |
| Drug Use For Unknown Indication |
8.8% |
| Type 2 Diabetes Mellitus |
6.4% |
| Prophylaxis Against Gastrointestinal Ulcer |
4.3% |
| Rheumatoid Arthritis |
3.9% |
| Pain |
3.4% |
| Cardiac Failure |
3.3% |
| Atrial Fibrillation |
3.2% |
| Diabetes Mellitus |
3.0% |
| Tachyarrhythmia |
3.0% |
| Chronic Obstructive Pulmonary Disease |
2.5% |
| Prophylaxis |
2.5% |
| Hyperlipidaemia |
2.4% |
| Pneumonia |
2.4% |
| Renal Failure |
2.2% |
| Urinary Tract Infection |
2.2% |
| Oedema |
2.1% |
| Hyperuricaemia |
2.0% |
| Pulmonary Arterial Hypertension |
1.7% |
|
| Renal Failure Acute |
13.5% |
| Transaminases Increased |
10.5% |
| Drug Interaction |
9.4% |
| Pneumonia |
7.0% |
| Syncope |
7.0% |
| Hypoglycaemia |
6.4% |
| Clostridium Difficile Colitis |
5.8% |
| Renal Failure |
4.7% |
| Thrombocytopenia |
4.7% |
| Urosepsis |
4.1% |
| Nausea |
3.5% |
| Death |
2.9% |
| Pleural Effusion |
2.9% |
| Pyrexia |
2.9% |
| Vomiting |
2.9% |
| Aortic Aneurysm Rupture |
2.3% |
| Electrocardiogram Qt Prolonged |
2.3% |
| Oedema Peripheral |
2.3% |
| Renal Impairment |
2.3% |
| Spinal Disorder |
2.3% |
|
| Interacting |
| Hypertension |
34.8% |
| Pain |
10.8% |
| Type 2 Diabetes Mellitus |
9.7% |
| Atrial Fibrillation |
7.7% |
| Prophylaxis Against Gastrointestinal Ulcer |
6.3% |
| Coronary Artery Disease |
5.4% |
| Rheumatoid Arthritis |
3.7% |
| Product Used For Unknown Indication |
2.8% |
| Hyperlipidaemia |
2.3% |
| Renal Impairment |
2.3% |
| Chronic Obstructive Pulmonary Disease |
2.0% |
| Intervertebral Discitis |
2.0% |
| Thrombosis Prophylaxis |
2.0% |
| Tachyarrhythmia |
1.7% |
| Ischaemic Heart Disease Prophylaxis |
1.4% |
| Cardiac Failure |
1.1% |
| Constipation |
1.1% |
| Prophylaxis |
1.1% |
| Cerebrovascular Accident |
0.9% |
| Gout |
0.9% |
|
| Renal Failure Acute |
54.8% |
| Dehydration |
9.5% |
| Hyperglycaemia |
7.1% |
| Drug Interaction |
4.8% |
| Osteoporotic Fracture |
4.8% |
| Gastrointestinal Haemorrhage |
2.4% |
| Hepatic Cirrhosis |
2.4% |
| Hypokalaemia |
2.4% |
| Melaena |
2.4% |
| Renal Failure Chronic |
2.4% |
| Renal Impairment |
2.4% |
| Tachyarrhythmia |
2.4% |
| Vomiting |
2.4% |
|
